OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cell-Free DNA Fragmentomics: The Novel Promising Biomarker
Ting Qi, Min Pan, Huajuan Shi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1503-1503
Open Access | Times Cited: 32
Ting Qi, Min Pan, Huajuan Shi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1503-1503
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Liquid Biopsy Based on Cell-Free DNA and RNA
Conor J. Loy, Lauren S. Ahmann, Iwijn De Vlaminck, et al.
Annual Review of Biomedical Engineering (2024) Vol. 26, Iss. 1, pp. 169-195
Closed Access | Times Cited: 13
Conor J. Loy, Lauren S. Ahmann, Iwijn De Vlaminck, et al.
Annual Review of Biomedical Engineering (2024) Vol. 26, Iss. 1, pp. 169-195
Closed Access | Times Cited: 13
Correspondence on Editorial regarding “Usefulness of circulating cell-free mitochondrial DNA on hepatocellular carcinoma diagnosis and prognosis assessment”
Yang Liu, Fan Peng, Siyuan Wang, et al.
Clinical and Molecular Hepatology (2025)
Open Access
Yang Liu, Fan Peng, Siyuan Wang, et al.
Clinical and Molecular Hepatology (2025)
Open Access
Mechanisms and technologies in cancer epigenetics
Zaki A. Sherif, Olorunseun O. Ogunwobi, Habtom W. Ressom
Frontiers in Oncology (2025) Vol. 14
Open Access
Zaki A. Sherif, Olorunseun O. Ogunwobi, Habtom W. Ressom
Frontiers in Oncology (2025) Vol. 14
Open Access
Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis
Norbert Moldován, Ymke van der Pol, Tom van den Ende, et al.
Cell Reports Medicine (2023) Vol. 5, Iss. 1, pp. 101349-101349
Open Access | Times Cited: 16
Norbert Moldován, Ymke van der Pol, Tom van den Ende, et al.
Cell Reports Medicine (2023) Vol. 5, Iss. 1, pp. 101349-101349
Open Access | Times Cited: 16
Liquid Biopsy in the Clinical Management of Cancers
Ho-Yin Ho, Kei-See Chung, Chau-Ming Kan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8594-8594
Open Access | Times Cited: 5
Ho-Yin Ho, Kei-See Chung, Chau-Ming Kan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8594-8594
Open Access | Times Cited: 5
Multibiomarker panels in liquid biopsy for early detection of pancreatic cancer – a comprehensive review
Kim-Lea Reese, Klaus Pantel, Daniel J. Smit
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 5
Kim-Lea Reese, Klaus Pantel, Daniel J. Smit
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 5
Cancer Bioenergetics and Tumor Microenvironments—Enhancing Chemotherapeutics and Targeting Resistant Niches through Nanosystems
Aisha Farhana, Abdullah Alsrhani, Yusuf S. Khan, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3836-3836
Open Access | Times Cited: 11
Aisha Farhana, Abdullah Alsrhani, Yusuf S. Khan, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3836-3836
Open Access | Times Cited: 11
Epigenetic modifications of cfDNA in liquid biopsy for the cancer care continuum
Jodie Wong, Rohit Muralidhar, Liang Wang, et al.
Biomedical Journal (2024), pp. 100718-100718
Open Access | Times Cited: 3
Jodie Wong, Rohit Muralidhar, Liang Wang, et al.
Biomedical Journal (2024), pp. 100718-100718
Open Access | Times Cited: 3
The impact of preanalytical variables on the analysis of cell-free DNA from blood and urine samples
Hongwei Peng, Ming Pan, Zongning Zhou, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Hongwei Peng, Ming Pan, Zongning Zhou, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 2
Liquid Biopsies Based on Cell-Free DNA Integrity as a Biomarker for Cancer Diagnosis: A Meta-Analysis
Ana María Rodríguez-Ces, Óscar Rapado‐González, Ángel Salgado‐Barreira, et al.
Diagnostics (2024) Vol. 14, Iss. 14, pp. 1465-1465
Open Access | Times Cited: 2
Ana María Rodríguez-Ces, Óscar Rapado‐González, Ángel Salgado‐Barreira, et al.
Diagnostics (2024) Vol. 14, Iss. 14, pp. 1465-1465
Open Access | Times Cited: 2
Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application
Zongyao Huang, Yao Fu, Yang Hong, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Zongyao Huang, Yao Fu, Yang Hong, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Plasma Circular RNAs as Biomarkers for Breast Cancer
Domenico Tierno, Gabriele Grassi, Fabrizio Zanconati, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 875-875
Open Access | Times Cited: 1
Domenico Tierno, Gabriele Grassi, Fabrizio Zanconati, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 875-875
Open Access | Times Cited: 1
Detection and characterization of pancreatic and biliary tract cancers using cell-free DNA fragmentomics
Xiaohan Shi, Shiwei Guo, Qiaonan Duan, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Xiaohan Shi, Shiwei Guo, Qiaonan Duan, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 1
Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer?
Lorenzo Foffano, Riccardo Vida, Alberto Piacentini, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 8, pp. 679-691
Closed Access | Times Cited: 1
Lorenzo Foffano, Riccardo Vida, Alberto Piacentini, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 8, pp. 679-691
Closed Access | Times Cited: 1
Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology
Wan Ying Tan, Snigdha Nagabhyrava, Olivia Ang-Olson, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 6533-6565
Open Access | Times Cited: 1
Wan Ying Tan, Snigdha Nagabhyrava, Olivia Ang-Olson, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 6533-6565
Open Access | Times Cited: 1
Plasma Cell‐Free DNA Concentration and Fragmentomes Predict Neoadjuvant Chemotherapy Response in Cervical Cancer Patients
Ting Peng, Haiqiang Zhang, Lingguo Li, et al.
Advanced Science (2024) Vol. 11, Iss. 43
Open Access | Times Cited: 1
Ting Peng, Haiqiang Zhang, Lingguo Li, et al.
Advanced Science (2024) Vol. 11, Iss. 43
Open Access | Times Cited: 1
Clinical Applications of Circulating Tumor DNA Profiling in GI Cancers
Francesca Battaglin, Heinz‐Josef Lenz
JCO Oncology Practice (2024) Vol. 20, Iss. 11, pp. 1481-1490
Closed Access | Times Cited: 1
Francesca Battaglin, Heinz‐Josef Lenz
JCO Oncology Practice (2024) Vol. 20, Iss. 11, pp. 1481-1490
Closed Access | Times Cited: 1
Liquid Biopsy as an Adjunct to Lung Screening Imaging
Nathaniel Deboever, Edwin J. Ostrin, Mara B. Antonoff
Deleted Journal (2023) Vol. 33, Iss. 4, pp. 411-419
Closed Access | Times Cited: 3
Nathaniel Deboever, Edwin J. Ostrin, Mara B. Antonoff
Deleted Journal (2023) Vol. 33, Iss. 4, pp. 411-419
Closed Access | Times Cited: 3
Fluorescent Chemo sensor nano-materials for Cancer bio-markers signalling: Towards development of non-invasive early detection strategies
Simon N. Mbugua
Dyes and Pigments (2023) Vol. 219, pp. 111603-111603
Closed Access | Times Cited: 2
Simon N. Mbugua
Dyes and Pigments (2023) Vol. 219, pp. 111603-111603
Closed Access | Times Cited: 2
The biological characteristics of long cell-free DNA in spent embryos culture medium as noninvasive biomarker in in-vitro embryo selection
Min Pan, Huajuan Shi, Ting Qi, et al.
Gene (2024) Vol. 927, pp. 148667-148667
Closed Access
Min Pan, Huajuan Shi, Ting Qi, et al.
Gene (2024) Vol. 927, pp. 148667-148667
Closed Access
Evaluation of cfDNA fragmentation characteristics in plasma for the diagnosis of lung cancer: A prospective cohort study
Fudong Xu, Chong Wang, Hongxia Li, et al.
Cancer Science (2024)
Open Access
Fudong Xu, Chong Wang, Hongxia Li, et al.
Cancer Science (2024)
Open Access
Considering Biomarkers of Neurodegeneration in Alzheimer’s Disease: The Potential of Circulating Cell-Free DNA in Precision Neurology
Chad Pollard, Erin R. Saito, Jeffrey M. Burns, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 11, pp. 1104-1104
Open Access
Chad Pollard, Erin R. Saito, Jeffrey M. Burns, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 11, pp. 1104-1104
Open Access
Advancing diagnosis and early risk assessment of preeclampsia through noninvasive cell-free DNA methylation profiling
Machteld Baetens, Bram Van Gaever, Stephanie Deblaere, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access
Machteld Baetens, Bram Van Gaever, Stephanie Deblaere, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access
The potential of circulating free DNA of methylated IGFBP as a biomarker for type 2 diabetes Mellitus: A Comprehensive review
Audrey Belinda, Farizky Martriano Humardani, Sulistyo Emantoko Dwi Putra, et al.
Clinica Chimica Acta (2024), pp. 120104-120104
Closed Access
Audrey Belinda, Farizky Martriano Humardani, Sulistyo Emantoko Dwi Putra, et al.
Clinica Chimica Acta (2024), pp. 120104-120104
Closed Access
Charting the Genomic Frontier
Jaclyn F. Hechtman, Brett Baskovich, Amber Fussell, et al.
Journal of Molecular Diagnostics (2024) Vol. 27, Iss. 1, pp. 6-11
Closed Access
Jaclyn F. Hechtman, Brett Baskovich, Amber Fussell, et al.
Journal of Molecular Diagnostics (2024) Vol. 27, Iss. 1, pp. 6-11
Closed Access
